Innovation Europe

Creating an Innovative Europe. Report of the Independent Expert Group on R D and Innovation appointed following the Hampton Court Summit and chaired by Mr Esko Aho, 2006. 

Nieoud R.M., Proeeedings of the Chiral Europe 96, Strasbourg, 14-15 Oetober 1996, Spring Innovation Ltd Publisher, Cheshire, SK7 IBA, 1996. 

Kinkel J.N., Proeeedings of Chiral Europe 95, 28-29 Sept. 1995, London, Published by Spring Innovation Ltd, Cheshire, SK7 IBA, England, 1995. 

Eraneotte E., Proeeedings of Chiral Europe 96, Strasbourg 14-15 Oetober 1996, Published by Spring Innovations Ltd, Stoeport, England, 1996. 

In Europe, a sponsor may request an accelerated review of a marketing authorisation by the EMEA on grounds that the product is of major interest to public health, particularly from the viewpoint of therapeutic innovation. If granted, an accelerated review must be conducted within 150 days as opposed to the 210 days allowed for a standard technical assessment. 

The overall competitiveness of the industries in Europe, Japan and the USA can be regarded as equivalent. But the better access to venture capital in the USA, and also in Canada, can give these countries an advantage, especially in developing innovative small and mediumsized companies. 

---